Plausible Improvements for Selective Targeting of Dopamine Receptors in Therapy of Parkinson's Disease

E-ISSN： 1875-5607|12|14|1556-1564

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.12, Iss.14, 2012-12, pp. : 1556-1564

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Nicotinic Receptors for Parkinson's Disease Therapy

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 651-658

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine D Receptors: Relevance for the Drug Treatment of Parkinson's Disease

By Levant B.

CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 391-402

Adis International

Access to resources Recommend Favorite

D1 and Functionally Selective Dopamine Agonists as Neuroprotective Agents in Parkinson's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 345-353

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic Optimisation of Dopamine Receptor Agonist Therapy for Parkinson's Disease

By Contin M. Riva R. Albani F. Baruzzi A.

CNS Drugs, Vol. 14, Iss. 6, 2000-12 ,pp. : 439-455

Adis International

Access to resources Recommend Favorite

Nicotinic receptors and Parkinson's disease

By Quik M. Jeyarasasingam G.

European Journal of Pharmacology, Vol. 393, Iss. 1, 2000-03 ,pp. : 223-230

Elsevier

Access to resources Recommend Favorite